| Drug Type Chemical drugs | 
| Synonyms P052 | 
| Target | 
| Action agonists | 
| Mechanism GCGR agonists(Glucagon receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseIND Approval | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | IND Approval | China  | 09 Sep 2025 | |
| Obesity | IND Approval | China  | 09 Sep 2025 | 





